캘리포니아의 혈우병 임상 시험
혈우병 관련 연구 15개가 캘리포니아 내 여러 지역에서 참여자를 모집하고 있습니다.
캘리포니아의 도시
공식 연구 텍스트(영어)
An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Children With Hemophilia A
- Loma Linda University Health, Loma Linda
피험자 모집 중관찰 연구
7세 ~ 12세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07088458A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
- Center for Inherited Blood Disorders, Orange
- University of California San Francisco, San Francisco
- Kaiser Permanente, Vallejo
피험자 모집 중1/2상
18세 이상 · 남성 · 2026. 11. 9. 업데이트됨 · NCT07226206Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
- University of California Davis Medical Center-Site Number: 8400005, Sacramento
피험자 모집 중4상
12세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06941870A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
- UC Davis Cancer Center, Sacramento
피험자 모집 중1/2상
2세 ~ 59세 · 남성 · 2026. 11. 5. 업데이트됨 · NCT05987449A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Center for Inherited Blood Disorders, Orange
피험자 모집 중3상
12세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07416604A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
- The Luskin Orthopaedic Institute for Children- Site Number : 8400013, Los Angeles
- Children's Hospital Los Angeles- Site Number : 8400002, Los Angeles
- The Center for Inherited Blood Disorders- Site Number : 8400009, Orange
- 외 1개
피험자 모집 중3상
1세 ~ 11세 · 남성 · 2026. 10. 27. 업데이트됨 · NCT07285460A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
- Altman Clinical and Translational Research Institute-IDS, La Jolla
- Altman Clinical and Translational Research Institute, La Jolla
- Orthopaedic Institute for Children/Orthopaedic Hemophilia Treatment Center, Los Angeles
- 외 1개
피험자 모집 중1상
12세 ~ 74세 · 남성 · 2026. 10. 15. 업데이트됨 · NCT06703606Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- The Regents of the University of California||UC Davis Health, Rancho Cordova
- UC Davis Health, Sacramento
- UC Davis Ambulatory Care Clinic, Sacramento
- 외 3개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 7. 업데이트됨 · NCT05568719A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
- Children's Hospital Los Angeles- Site Number : 8400005, Los Angeles
피험자 모집 중4상
12세 이상 · 남성 · 2026. 9. 23. 업데이트됨 · NCT06145373Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Lucile Packard Children's Hospital, Palo Alto
피험자 모집 중관찰 연구건강한 지원자 환영
0세 ~ 20세 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT04278404ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Orthopaedic Institute for Children HTC, Los Angeles
- Childrens Hospital Los Angeles, Los Angeles
- UCSF Benioff Children's Hospital Oakland, Oakland
- 외 5개
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT04398628Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Stanford University, Palo Alto
- Rady Children's Hospital, San Diego
피험자 모집 중관찰 연구
6세 ~ 19세 · 모든 성별 · 2026. 7. 2. 업데이트됨 · NCT05022459A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- Children's Hospital Los Angeles, Los Angeles
피험자 모집 중1상건강한 지원자 환영
18세 ~ 60세 · 모든 성별 · 2026. 7. 2. 업데이트됨 · NCT06349473Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD), Orange
- Stanford University: Stanford Children's Health, Redwood City
피험자 모집 중1상
0세 ~ 90세 · 모든 성별 · 2026. 4. 3. 업데이트됨 · NCT05500807SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Orthopaedic Institute for Children, Los Angeles
- University of California at Davis UC Davis Hemostasis and Thrombosis Center, Sacramento
피험자 모집 중4상
12세 ~ 100세 · 모든 성별 · 2026. 1. 12. 업데이트됨 · NCT04647227ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.